Skip to main content
. 2020 Dec 8;13:1756286420970833. doi: 10.1177/1756286420970833

Table 1.

Interferon-beta preparations in patients with CIS and RR-MS treated with interferon beta.

Interferon-beta preparations Number (%)
Avonex 11 (9.5)
Rebif 22 mcg 11 (9.5)
Rebif 44 mcg 62 (53.5)
Betaferon 28 (24.1)
Plegridy 4 (3.4)
Total 116 (100)

Treatment duration with interferon-beta ranged from 1 to 12 months (mean 10.4 months); 85/116 (73.3%) were treated for 12 months.

CIS, clinically isolated syndrome; RR-MS, relapsing-remitting multiple sclerosis.